SCHEMBL19475271

SCHEMBL19475271

O=C(O)Nc1ccc(-c2cc(N3CCOCC3)c3ccccc3n2)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MOK Q9UQ07 9/20 0.84
NPSR1 Q6W5P4 1/20 0.60
METAP1 P53582 1/20 0.57
AHR P35869 1/20 0.57
MAPT P10636 5/20 0.56
GPR55 Q9Y2T6 1/20 0.56
NCF1 P14598 1/20 0.56
KDM4E B2RXH2 4/20 0.56
ALDH1A1 P00352 2/20 0.56
NPC1 O15118 1/20 0.56
HCRTR1 O43613 1/20 0.56
LMNA P02545 1/20 0.56
GAA P10253 1/20 0.56
RAB9A P51151 1/20 0.56
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
HPGD P15428 1/20 0.54
MAPK1 P28482 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19475531 0.91 MOK (1.00) MOKNPSR1MAPTKDM4EALDH1A1
SCHEMBL19475310 0.87 MOK (0.77) MOKNPSR1METAP1AHRMAPT
SCHEMBL14478814 0.81 MOK (0.65) MOKMETAP1AHRMAPTGPR55
SCHEMBL19475328 0.81 NCF1 (0.67) MOKMETAP1AHRMAPTGPR55
SCHEMBL1385200 0.79 MOK (0.55) MOKNPSR1MAPTNCF1KDM4E
SCHEMBL1385196 0.79 MOK (0.55) MOKNPSR1MAPTNCF1KDM4E
Thiophene SCHEMBL5496494 0.76 MOK (0.52) MOKMETAP1MAPTNCF1KDM4E
Thiophene SCHEMBL5496485 0.76 MOK (0.52) MOKMETAP1MAPTNCF1KDM4E
SCHEMBL29965740 0.76 MOK (0.59) MOKNPSR1MAPTGPR55KDM4E
SCHEMBL28581710 0.76 MOK (0.59) MOKNPSR1MAPTGPR55KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, HMGB1, GPR119 MOK 4420/4885NPSR1 442/4885METAP1 3505/4885
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof AGER, HMGB1, GPR119 MOK 4420/4885NPSR1 442/4885METAP1 3505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.